World Orphan Drug Congress Europe 2027
World Orphan Drug Congress Europe is Terrapinn's conference and exhibition on rare disease and orphan drug development, access and policy. It draws pharma and biotech executives, regulators, HTA bodies, patient groups and service providers.
Dates not announced yet
Check the official site for updates
Organizer
Published by the organizer
Every year
How often it's held
Checked November 2, 2026
Reported attendance
1,500+
attendees · year not stated
Reported exhibitors
Not published
About World Orphan Drug Congress Europe 2027
World Orphan Drug Congress Europe is Terrapinn's annual conference and exhibition on rare disease and orphan drug development, access and policy. It brings together pharma and biotech companies, regulators, HTA bodies, patient groups, investors and service providers. Terrapinn hasn't announced dates or a venue for the 2027 edition yet. The latest edition ran 26 to 28 October 2026 at RAI Amsterdam, with a workshop day and two conference and exhibition days. The organizer cites 1,500+ attendees and 250+ speakers for the event, without giving a year.
250+
Speakers
1,000+
1-to-1 partnering meetings
10,000+
Networking connections
3
Event days
What happens at World Orphan Drug Congress Europe
The congress combines a multi-track conference, an exhibition, partnering meetings and pre-congress workshops. Terrapinn says it covers the whole orphan drug value chain, from cell and gene therapy and genetic testing to market access and real-world evidence.
The 2026 edition opened on 26 October with workshops on AI, early access, the patient journey and EU joint clinical assessment. Five keynote panels followed on 27 and 28 October. They covered the EU pharmaceutical legislation review, new rare disease breakthroughs, EU joint clinical assessments, patient involvement and the future of rare disease policy.
Conference tracks in 2026 covered access and pricing, cell and gene therapy, clinical development, investment, manufacturing and patient centricity. Precision medicine, real-world evidence and science strategy had tracks too. A BioPharma Showcase stage gave drug developers 15-minute pitches to investors and decision makers.
The 2026 floor also held a Start-up Zone, a Patient Zone and a Media Zone. Small working groups replaced the earlier roundtable format. The event holds CPD accreditation from The CPD Group, so attendees can collect CPD credits and certificates.
Who attends World Orphan Drug Congress Europe
The audience spans drug developers, regulators, payers, patient advocates and the service providers that support them. Cell and Gene Therapy Insights described 1,500+ delegates from government, patient organizations and industry in its 2026 preview.
- Gold Sponsor12
- Silver Sponsor6
- Bronze Sponsor4
- Associate Sponsor3
- Exhibitor5
- Supporting Partner & Exhibitor4
- Startup Plus4
- Startup14
Our count of the official 2026 sponsors and exhibitors page, 2 November 2026. Terrapinn's own listing is left out.2026 · terrapinn.com ↗
Terrapinn's own attendance figures vary by page and carry no year. The home page cites 1,500+ attendees, the VIP pass page cites 1,800+ attendees, and the sponsor page mentions an expert audience of 2,000. Terrapinn's 2025 announcement said the first Amsterdam edition would bring over 2,000 attendees.
Terrapinn offers complimentary VIP passes to eligible people from pharma and biotech, patient advocacy, charities, investment, academia and public health. Patient advocacy groups can apply for free passes. The organizer says representatives of EURORDIS, ERDERA, IRDiRC, Beacon, the Dravet Syndrome Foundation and FEDER have joined.
Terrapinn hasn't published a breakdown of attendees by job role, seniority or country. Its 2025 post-event report and a sample attendee list are offered through forms on the event site.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| Not stated | 1,500+attendeesOrganizer figure shown without a yearterrapinn.com ↗ |
Companies at World Orphan Drug Congress Europe 2026
Terrapinn's 2026 sponsors and exhibitors page names 52 companies and organizations, by our count on 2 November 2026. Big pharma sponsors included Sanofi, Takeda, Ipsen, Chiesi Global Rare Diseases and Alexion. Contract research organizations such as ICON, Parexel and Worldwide Clinical Trials sponsored too.
Sponsors (25)Alexion Pharma Netherlands B.V., Amiculum Business Services Ltd, CENTOGENE GmbH and 22 more
- Alexion Pharma Netherlands B.V. · 2026Gold Sponsor, AstraZeneca's rare disease business
- Amiculum Business Services Ltd · 2026Gold Sponsor, a healthcare consulting and communications agency
- CENTOGENE GmbH · 2026Gold Sponsor, a genetic diagnostics company based in Rostock
- Chiesi Global Rare Diseases · 2026Gold Sponsor, a rare disease business unit of the Chiesi Group
- ICON Clinical Research Ltd · 2026Gold Sponsor, a clinical research organization
- Ipsen · 2026Gold Sponsor
- Parexel International LLC · 2026Gold Sponsor, a clinical research organization
- Primevigilance · 2026Gold Sponsor
- RTI Health Solutions · 2026Gold Sponsor
- Sanofi · 2026Gold Sponsor
- Staatz Consulting · 2026Gold Sponsor, a business development and market access consultancy
- Takeda · 2026Gold Sponsor
- OXON Epidemiology · 2026Silver Sponsor, a contract research organization focused on real-world evidence
- PANTHERx Rare · 2026Silver Sponsor, a rare disease specialty pharmacy
- Premier Research · 2026Silver Sponsor
- SGS CDMO Solutions · 2026Silver Sponsor
- subrosa Health & Capital · 2026Silver Sponsor
- Worldwide Clinical Trials · 2026Silver Sponsor
- e-Projection K.K. · 2026Bronze Sponsor
- Norgine · 2026Bronze Sponsor
- Sciensus Pharma Services Limited · 2026Bronze Sponsor
- York Health Economics Consortium · 2026Bronze Sponsor, a health economics consultancy owned by the University of York
- Alchemist Consulting Ltd · 2026Associate Sponsor, a provider of pharma and healthcare compliance services
- Camino Communications · 2026Associate Sponsor, a rare disease communications agency
- Opis S.R.L. · 2026Associate Sponsor
Exhibitors (28)Coronado Research, Granzer Regulatory Consulting & Services GmbH, Ikris Pharma Network and 25 more
- Coronado Research · 2026Exhibitor
- Granzer Regulatory Consulting & Services GmbH · 2026Exhibitor, a regulatory consultancy for drug and device development
- Ikris Pharma Network · 2026Exhibitor
- Linx, KU Leuven · 2026Exhibitor
- Medizone Germany GmbH · 2026Exhibitor, a pharmaceutical wholesaler sourcing comparator products
- ERDERA · 2026Supporting Partner & Exhibitor
- FH Europe Foundation NGO · 2026Supporting Partner & Exhibitor, a European patient network for inherited lipid conditions
- Pathways To Trust · 2026Supporting Partner & Exhibitor, a rare disease patient advocacy organization
- RARE Revolution · 2026Supporting Partner & Exhibitor
- Genontech Digital Health Solutions Ltd. · 2026Startup Plus, a Hungarian digital health start-up
- Numiera Therapeutics · 2026Startup Plus
- Oddifact · 2026Startup Plus
- One2Treat · 2026Startup Plus, a developer of software to assess the medical value of therapies
- Evidax · 2026Startup, a provider of comparative evidence for market access
- Hyvv · 2026Startup, a clinical trial intelligence platform
- Infirmacea Inc. · 2026Startup, a preclinical DNA medicines company founded in Japan
- iniuva GmbH · 2026Startup, a developer of pharmacological chaperones for rare genetic diseases
- Innvocept Global Solutions · 2026Startup, contract research organization
- MedRyge · 2026Startup
- NIXI Design for Health SL · 2026Startup, a Barcelona health innovation company for children
- Olavide Neuron STX (ONESTX) · 2026Startup, a developer of therapies for neurodegenerative conditions
- OpalMedica · 2026Startup, a UK medtech company tackling diagnostic delays
- Orphanet-AISBL · 2026Startup, a non-profit making rare disease data more usable
- Phormulate · 2026Startup
- Transmineo · 2026Startup, a health data and evidence platform
- Unboxed Psychology · 2026Startup
- Unravel Biosciences · 2026Startup, a clinical-stage therapeutics company
- Worldwide Clinical Trials · 2025Booth 10311 at the 2025 edition in Amsterdam
The list also included 18 start-ups across the Startup and Startup Plus packages. Worldwide Clinical Trials confirmed its presence at the 2025 edition as well, with booth 10311 in Amsterdam.
Exhibitors at World Orphan Drug Congress Europe
The 2026 exhibition mixed sponsor stands, standard exhibitors, supporting partners and a Start-up Zone. Terrapinn's home page cites 70+ exhibitors without a year. Its 2025 announcement put the first Amsterdam show at over 130 exhibitors.
Standard exhibitors in 2026 included Coronado Research, Granzer Regulatory Consulting & Services, Ikris Pharma Network, Linx at KU Leuven and Medizone Germany. ERDERA, FH Europe Foundation, Pathways To Trust and RARE Revolution exhibited as supporting partners.
Companies book through Terrapinn's sponsor and exhibit page, and stand prices come in the prospectus. A shell scheme stand includes white walls, carpet and a nameboard. Furniture, graphics, electrics and lighting are ordered from the RAI webshop. The exhibitor manual opens about four months before the show.
Start-ups under five years old with fewer than 15 employees could book a 2026 Start-up package for €500. It included a 1 meter booth, up to three passes and basic app access. A 5-minute Expo Stage pitch cost €1,000 more, and full app access with lead retrieval cost €250.
Rare disease dealmakers also meet at BIO-Europe Spring 2027, a partnering event for the wider biotech industry.
Sponsors and partners at World Orphan Drug Congress Europe
Sponsorship runs in tiers that bundle speaking slots, branding and meetings. Terrapinn's sponsor packages range from an exclusive keynote title to Diamond, Platinum, Gold, Silver and Bronze speaking options. Diamond sponsors join a plenary panel, Platinum sponsors lead a track, and Bronze sponsors host a working group. Branding options include the networking reception, lanyards or bags, the registration desk and the floor plan.
The 2026 Gold Sponsors were Alexion, Amiculum, CENTOGENE, Chiesi Global Rare Diseases, ICON, Ipsen, Parexel, Primevigilance, RTI Health Solutions, Sanofi, Staatz Consulting and Takeda. Silver Sponsors were OXON Epidemiology, PANTHERx Rare, Premier Research, SGS CDMO Solutions, subrosa Health & Capital and Worldwide Clinical Trials. Bronze Sponsors were e-Projection, Norgine, Sciensus and York Health Economics Consortium. Alchemist Consulting, Camino Communications and Opis were Associate Sponsors.
Supporting partners in 2026 included IRDiRC, EATRIS, EuropaBio, HollandBio, Health-Holland and several European Reference Networks, per the partners page. IRDiRC said it would take part in discussions at the 2026 edition. Teams that manage many sponsor deals can compare event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
World Orphan Drug Congress Europe attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
Terrapinn publishes its exhibitor and sponsor list online, but it doesn't publish an attendee list. The 2026 sponsors and exhibitors page lists each company with its package, from Gold Sponsor to Startup.
Registered attendees see the attendee list inside the Terrapinn Events App, which opens a few weeks before the show. Exhibitors with premium app access get the attendee list, badge scanning, lead capture and lead export. Delegates with full app access can book 1-to-1 meetings, a form of event matchmaking.
Sponsors who buy facilitated meetings receive the attendee list about four weeks before the event to choose meeting targets. Terrapinn warns that it doesn't work with third parties for accommodation, travel or data services. Lists sold by outside vendors don't come from the organizer.
Our guide explains how to find who's attending an event. We also compare event intelligence platforms that track companies at events like this one.
See who's attending World Orphan Drug Congress Europe
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at World Orphan Drug Congress Europe 2027
World Orphan Drug Congress Europe hasn't announced its 2027 speakers yet. Terrapinn's speaker page still shows the 2026 lineup, and the list below covers that edition.
World Orphan Drug Congress Europe hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
At the 2026 edition, the keynote panels brought together regulators, HTA bodies, industry and patient groups. The opening panel on EU pharmaceutical legislation included Kristina Larsson of the EMA, Stine Bosse of the European Parliament and Toon Digneffe of Takeda. Enrico Costa of the Italian Medicines Agency moderated it.
The 2026 HTA keynote featured Niklas Hedberg of TLV, Anne Willemsen of Zorginstituut Nederland and Stephanie Said of G-BA. Karen Facey of the University of Edinburgh moderated. Yann Le Cam moderated the closing panel with Ravi Ram of Rare Diseases International and Daria Julkowska of ERDERA.
Company speakers in 2026 came from Biogen, Sanofi, Chiesi Group, PTC Therapeutics, Ascendis Pharma, Boehringer Ingelheim and CSL, among others. Patient voices included EURORDIS, The Ehlers-Danlos Society and Children's Tumor Foundation Europe. Speaking enquiries go to the team on Terrapinn's contact page, and sponsor packages include paid speaking slots.
Who spoke at World Orphan Drug Congress Europe 2026 (50)
- Enrico Costa, Head of International Affairs Office and Italian Delegate at the COMP, Italian Medicines Agency (AIFA)
- Kristina Larsson, Head of Orphan Medicines, Division for Human Medicines Evidence Generation, European Medicines Agency
- Stine Bosse, Member of the European Parliament, Renew Europe Group, European Parliament
- Kaja Kantorska, Health and Food Safety Directorate General, European Commission
- Toon Digneffe, Head Public Affairs and Public Policy, Takeda
- Jean Saslawsky, CEO, EURORDIS - Rare Diseases Europe
- Sheela Upadhyaya, Rare Disease Consultant, Rarely Ordinary
- Violeta Stoyanova-Beninska, Senior Scientific Specialist, Human Division, European Medicines Agency
- P.J. Brooks, Deputy Director, Division of Rare Diseases Research Innovation, NIH/NCATS
- Adrian Haigh, Senior Vice President and General Manager EMEA and Asia Pacific Region, PTC Therapeutics
- Mohit Jain, Vice President, Market Access and Pricing, Europe and International, Ascendis Pharma
- Karen Facey, Senior HTA Advisor, University of Edinburgh
- Niklas Hedberg, Chief Pharmacist, Tandvards och Lakemedelsformansverket (TLV)
- Anne Willemsen, Chair JCA Subgroup, Zorginstituut Nederland
- Alexander Natz, Secretary General, EUCOPE
- Stephanie Said, Coordination EU HTA Medicinal Products and Chair of the HTA JSC Subgroup, G-BA
- Tanja Podkonjak, Head of Access Readiness and Intelligence, Takeda
- Anneliene Jonker, Rare Disease Therapy Researcher, University of Twente
- Maurizio Scarpa, Director, Rare Disease Program IRCCS San Gerardo dei Tintori, MetabERN
- Dariusz Adamczewski, Managing Director, Children's Tumor Foundation Europe
- Yann Le Cam, Founder and Former CEO, EURORDIS, and Strategy Advisor, VOZ Advisors
- Alexis Arzimanoglou, Coordinator of the European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE
- Daria Julkowska, Head of Strategy and Partnerships in Health, ERDERA - INSERM
- Ravi Ram, CEO, Rare Diseases International
- Valentina Bottarelli, Head of Policy and Public Affairs, EURORDIS - Rare Diseases Europe
- Michael Andreou, Value and Access Lead, Rare Diseases, Biogen
- Andrea Ballerini, Medical Director, Italfarmaco
- Jana Benesh, Director of Therapeutic Expertise, ICON Centre for Rare Diseases
- Lara Bloom, President and CEO, The Ehlers-Danlos Society
- Adam Bloomfield, Vice President Medical Affairs, Premier Research
- Paul Broomhead, Head of Site, SGS Integrated CDMO Solutions
- Ramya Devanand, Head of BD Search and Evaluation, Norgine
- Pedro Franco, Senior Director, Head of Europe Global Regulatory and Scientific, Merck Serono
- Maja Gasparic, Global Medical Director, Sanofi
- Vinciane Pirard, Medical, SAI, and Chair of IRDiRC Companies Constituent Committee, Sanofi
- Enrico Piccinini, Senior Vice President, EU and International, Rare Diseases, Chiesi Group
- James Levine, President, Fondation Ipsen
- Tom Pulles, VP, Head of Medical Affairs and Patient Advocacy, Europe, Acadia Pharmaceuticals
- Kwee Lan Tan, Head of Team RRL, Boehringer Ingelheim
- Batyrkhan Kuatov, Director HEOR, Global Market Access, CSL
- Panteli Theocharous, Chief Therapeutics and Clinical Strategy Officer and President of Europe, Worldwide Clinical Trials
- Jay Weaver, VP, Payer Solutions, PANTHERx Rare
- Nawab Qizilbash, CMO and Associate Professor, OXON Epidemiology
- Claudia Roca Herms, Corporate Director Patient Advocacy and Public Affairs, Ferrer
- Laure Nas de Tourris, Partner, Clarivate
- Claire Skentelbery, Director General, EuropaBio
- Matthias Heck, Senior Advisor, EUCOPE
- Daniel O'Connor, Executive Director Regulation, ABPI
- Kelly Pluschke, Scientific Administrator, European Medicines Agency
- Clara van Karnebeek, Professor, Emma Center of Personalized Medicine, Amsterdam UMC
Dates, venue and getting there
Terrapinn hasn't announced dates or a venue for World Orphan Drug Congress Europe 2027. The event has run each October in recent years, and the last two editions were at RAI Amsterdam.
The 2026 edition ran 26 to 28 October, with workshops on Monday 26 October. Conference days started at 9 a.m. and ran until 5.40 p.m. on Tuesday and 4 p.m. on Wednesday.
The venue was Hall 10 at RAI Amsterdam, Europaplein 24, with badge collection at Entrance E. Terrapinn said Amsterdam is home to 400+ pharma, biotech, research and healthcare organizations working on rare disease. Confirmed delegates could get discounted Eurostar tickets, and Terrapinn offered discounted rooms through RAI Hotel Services.
The 2025 edition also ran at RAI Amsterdam, from 27 to 29 October 2025.
Tickets and registration
World Orphan Drug Congress Europe is a paid professional conference with free passes for some groups. Registration for the 2026 edition has closed, and Terrapinn hasn't published 2027 prices yet.
For the 2025 edition, RAI Amsterdam listed tickets from €495 to €3,195. We checked in November 2026.
Patient advocacy groups can apply for complimentary passes, subject to Terrapinn's approval. VIP passes are free for eligible people from pharma and biotech, patient groups, charities, investors, academia and public health. VIP passes don't include full app access.
Full app access adds messaging and 1-to-1 meeting booking with other attendees, per the event app page. Limited access covers the agenda, floor plan and exhibitors only.
History of World Orphan Drug Congress Europe
Terrapinn runs the congress alongside other life science events such as World Vaccine Congress Europe. The 2024 edition ran 22 to 25 October in Barcelona, according to EURORDIS.
In 2025 the congress moved to Amsterdam. Terrapinn's announcement called it the first Amsterdam edition, held at the RAI Convention Centre.
Terrapinn also ran a US edition of the congress for more than a decade. In 2026 it said it won't run World Orphan Drug Congress USA in 2027. It pointed rare disease attendees to the European congress and its World Evidence Pricing & Access Congress events.
Resources for exhibitors, sponsors and attendees
These official Terrapinn pages cover booking, the program and travel.
- Sponsor and exhibitFor packages, the prospectus and booking enquiries.
- 2026 sponsors and exhibitorsFor the latest official list with packages.
- Sponsor packagesFor speaking, branding and facilitated meeting options.
- Start-up ZoneFor the start-up booth package and eligibility rules.
- Sponsor and exhibitor FAQsFor stand build, shipping and staff passes.
- 2026 speakersAnd the 2026 agenda for the latest program.
- Event app guideFor app access levels and meeting booking.
- Patient advocacy group passesAnd VIP pass eligibility for free registration.
- Venue informationAnd hotel booking for travel planning.
- Attendee FAQsFor timings, registration and the app.
- Contact the teamFor sponsorship, speaking, press and start-up enquiries.